nach oben

Current Treatment Options in Gastroenterology

Erschienen in:

01.03.2018 | Esophagus (PG Iyer, Section Editor)

Endoscopic Treatments of GERD

verfasst von: Carol Rouphael, MD, Ruthvik Padival, MD, Madhusudhan R. Sanaka, MD, Prashanthi N. Thota, MD

Erschienen in: Current Treatment Options in Gastroenterology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Opinion statement

Purpose of review

Endoscopic therapies for gastroesophageal reflux disease (GERD) are minimally invasive techniques which fill the gap between the medical therapy with proton pump inhibitors (PPIs) and surgical fundoplication. The main endoscopic therapies currently available in the USA are transoral incisionless fundoplication (TIF) using EsophyX device or less commonly, Medigus Ultrasonic Surgical Endostapler, and radiofrequency energy delivery to lower esophageal sphincter using Stretta device. Our aim was to examine the available evidence for these therapies.

Recent findings

Consistent evidence for subjective improvement is available for fundoplication using EsophyX and Stretta, but improvement in objective parameters for GERD is not seen or evaluated in all the studies. There is a reduction in long-term efficacy seen with TIF and also to a lesser extent with Stretta.

Summary

Endoscopic therapies do not replace surgical fundoplication and therefore are useful in patients with breakthrough symptoms on PPI such as regurgitation or those reluctant to take long-term PPI. An ideal patient is one who has symptoms and objective evidence of GERD such as abnormal pH study or erosive esophagitis without any significant anatomic distortion such as a hiatal hernia. Since these are endoluminal procedures, they do not address the hiatal hernia reduction or repair of crural defect. Adequate training in the technique and careful patient selection are essential prior to embarking on these procedures.

Richter JE. The patient with refractory gastroesophageal reflux disease. Dis Esophagus. 2006;19:443–7. https://doi.org/10.1111/j.1442-2050.2006.00619.x.CrossRefPubMed

Vaezi MF, Yang YX, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterology. 2017;153:35–48. https://doi.org/10.1053/j.gastro.2017.04.047.CrossRefPubMed

Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–28. https://doi.org/10.1038/ajg.2012.444.CrossRefPubMed

•• Pearl J, Pauli E, Dunkin B, Stefanidis D. SAGES endoluminal treatments for GERD. Surg Endosc. 2017;3:3783–90. https://doi.org/10.1007/s00464-017-5639-1. This article represents the 2017 SAGES review on “endoluminal treatments for GERD.”CrossRef

•• ASGE Technology Committee, Thosani N, Goodman A, Manfredi M, Navaneethan U, Parsi MA, et al. Endoscopic anti-reflux devices [with videos]. Gastrointest Endosc. 2017;86:931–48. https://doi.org/10.1016/j.gie.2017.08.001. This article represents the 2017 ASGE review on “endoscopic anti-reflux devices.”CrossRef

Auyang ED, Carter P, Rauth T, Fanelli RD, SAGES Guidelines Committee. SAGES clinical spotlight review: endoluminal treatments for gastroesophageal reflux disease [GERD]. Surg Endosc. 2013;27:2658–72. https://doi.org/10.1007/s00464-013-3010-8.CrossRefPubMed

Fass R. An overview of transoral incisionless fundoplication and magnetic sphincter augmentation for GERD. Gastroenterol Hepatol. 2017;13:50–2.

Nissen R. A simple operation for control of reflux esophagitis. Schweiz Med Wochenschr. 1956;86(Suppl 20):590–2. German

Dallemagne B, Weerts JM, Jehaes C, Markiewicz S, Lombard R. Laparoscopic Nissen fundoplication: preliminary report. Surg Laparosc Endosc. 1991;1:138–43.PubMed

10.

Ebright MI, Sridhar P, Litle VR, Narsule CK, Daly BD, Fernando HC. Endoscopic fundoplication: effectiveness for controlling symptoms of gastroesophageal reflux disease. Innovations [Phila]. 2017;12:180–5. https://doi.org/10.1097/IMI.0000000000000351.

11.

Frazzoni M, Conigliaro R, Manta R, Melotti G. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther. 2011;34:67–75. https://doi.org/10.1111/j.1365-2036.2011.04677.x.CrossRefPubMed

12.

Testoni PA, Vailati C, Testoni S, Corsetti M. Transoral incisionless fundoplication [TIF 2.0] with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome. Surg Endosc. 2012;26:1425–35. https://doi.org/10.1007/s00464-011-2050-1.CrossRefPubMed

13.

Hunter JG, Kahrilas PJ, Bell RCW, Wilson EB, Trad KS, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148:324–33. https://doi.org/10.1053/j.gastro.2014.10.009.CrossRefPubMed

14.

Trad KS, Fox MA, Simoni G, Shughoury AB, Mavrelis PG, et al. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm. Surg Endosc. 2017;31:2498–508. https://doi.org/10.1007/s00464-016-5252-8.CrossRefPubMed

15.

Wendling MR, Melvin WS, Perry KA. Impact of transoral incisionless fundoplication [TIF] on subjective and objective GERD indices: a systematic review of the published literature. Surg Endosc. 2013;27:3754–61. https://doi.org/10.1007/s00464-013-2961-0.CrossRefPubMed

16.

Huang X, Chen S, Zhao H, Zeng X, Lian J, et al. Efficacy of transoral incisionless fundoplication [TIF] for the treatment of GERD: a systematic review with meta-analysis. Surgical Endoscopy. 2017;31:1032–44. https://doi.org/10.1007/s00464-016-5111-7.CrossRefPubMed

17.

Toomey P, Teta A, Patel K, Ross S, Sukharamwala P, Rosemurgy AS. Transoral incisionless fundoplication: is it as safe and efficacious as a Nissen or Toupet fundoplication? Am Surg. 2014;80:860–7.PubMed

18.

Testoni PA, Testoni S, Mazzoleni G, Vailati C, Passaretti S. Long-term efficacy of transoral incisionless fundoplication with Esophyx [Tif 2.0] and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc. 2015;29:2770–80. https://doi.org/10.1007/s00464-014-4008-6.CrossRefPubMed

19.

Stefanidis G, Viazis N, Kotsikoros N, Tsoukalas N, Lala E, et al. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy. Dis Esophagus. 2017;30:1–8. https://doi.org/10.1111/dote.12525.PubMed

20.

Svoboda P, Kantorová I, Kozumplík L, Scheer P, Radvan M, et al. Our experience with transoral incisionless plication of gastroesophageal reflux disease: NOTES procedure. Hepatogastroenterology. 2011;58:1208–13. https://doi.org/10.5754/hge10108.CrossRefPubMed

21.

Håkansson B, Montgomery M, Cadiere GB, Rajan A, Bruley des Varannes S, et al. Randomized clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther. 2015;42:1261–70. https://doi.org/10.1111/apt.13427.CrossRefPubMed

22.

Triadafilopoulos G. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease. World J Gastroenterol. 2014;20:7730–8. https://doi.org/10.3748/wjg.v20.i24.7730.CrossRefPubMedPubMedCentral

23.

Brar TS, Draganov PV, Yang D. Endoluminal therapy for gastroesophageal reflux disease: in between the pill and the knife? Dig Dis Sci. 2017;62:16–25. https://doi.org/10.1007/s10620-016-4355-3.CrossRefPubMed

24.

Noar M, Squires P, Noar E, Lee M. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later. Surg Endosc. 2014;28:2323–33. https://doi.org/10.1007/s00464-014-3461-6.CrossRefPubMed

25.

Richards WO, Houston HL, Torquati A, Khaitan L, Holzman MD, et al. Paradigm shift in the management of gastroesophageal reflux disease. Ann Surg. 2003;237:638–49.PubMedPubMedCentral

26.

Kahrilas PJ. Radiofrequency energy treatment of GERD. Gastroenterology. 2003;125:970–3.CrossRefPubMed

27.

Arts J, Bisschops R, Blondeau K, Farré R, Vos R, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol. 2012;107:222–30. https://doi.org/10.1038/ajg.2011.395.CrossRefPubMed

28.

Noar M, Squires P, Khan S. Radiofrequency energy delivery to the lower esophageal sphincter improves gastroesophageal reflux patient-reported outcomes in failed laparoscopic Nissen fundoplication cohort. Surg Endosc. 2017;31:2854–62. https://doi.org/10.1007/s00464-016-5296-9.CrossRefPubMed

29.

Corley DA, Katz P, Wo JM, Stefan A, Patti M, et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003;125:668–76.CrossRefPubMed

30.

Coron E, Sebille V, Cadiot G, Zerbib F, Ducrotte P, et al. Consortium de Recherche Indépendant sur le Traitement et L’exploration du Reflux Gastro-oesophagien et de L’endobrachyoesophage [CRITERE]. Clinical trial: radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients. Aliment Pharmacol Ther. 2008;28:1147–58. https://doi.org/10.1111/j.1365-2036.2008.03790.x.CrossRefPubMed

31.

Aziz AM, El-Khayat HR, Sadek A, Mattar SG, McNulty G, et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24:818–25. https://doi.org/10.1007/s00464-009-0671-4.CrossRefPubMed

32.

Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech. 2012;22:283–8. https://doi.org/10.1097/SLE.0b013e3182582e92.CrossRefPubMed

33.

Lipka S, Kumar A, Richter JE. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13:1058–67. https://doi.org/10.1016/j.cgh.2014.10.013.CrossRefPubMed

34.

Dughera L, Rotondano G, De Cento M, Cassolino P, Cisarò F. Durability of Stretta radiofrequency treatment for GERD: results of an 8-year follow-up. Gastroenterol Res Pract. 2014;2014:531907. https://doi.org/10.1155/2014/531907.CrossRefPubMedPubMedCentral

35.

Zacherl J, Roy-Shapira A, Bonavina L, Bapaye A, Kiesslich R, Schoppmann SF, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler [MUSE^TM] for gastroesophageal reflux disease: 6-month results from a multicenter prospective trial. Surg Endosc. 2015;29:220–9. https://doi.org/10.1007/s00464-014-3731-3.CrossRefPubMed

36.

Kim HJ, Kwon CI, Kessler WR, Selzer DJ, McNulty G, et al. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSETM endoscopic stapling device. Surg Endosc. 2016;30:3402–8. https://doi.org/10.1007/s00464-015-4622-y.CrossRefPubMed

37.

Roy-Shapira A, Bapaye A, Date S, Pujari R, Dorwat S. Trans-oral anterior fundoplication: 5-year follow-up of pilot study. Surg Endosc. 2015;29:3717–21. https://doi.org/10.1007/s00464-015-4142-9.CrossRefPubMedPubMedCentral

38.

Danalioglu A, Cipe G, Toydemir T, Kocaman O, Ince AT, et al. Endoscopic stapling in comparison to laparoscopic fundoplication for the treatment of gastroesophageal reflux disease. Dig Endosc. 2014;26:37–42. https://doi.org/10.1111/den.12081.CrossRefPubMed

Titel: Endoscopic Treatments of GERD
verfasst von: Carol Rouphael, MD
Ruthvik Padival, MD
Madhusudhan R. Sanaka, MD
Prashanthi N. Thota, MD
Publikationsdatum: 01.03.2018
Verlag: Springer US
Erschienen in: Current Treatment Options in Gastroenterology / Ausgabe 1/2018
Print ISSN: 1092-8472
Elektronische ISSN: 1534-309X
DOI: https://doi.org/10.1007/s11938-018-0170-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Endoscopic Treatments of GERD